Allergen, Individual-Micro organism Aspergillus Fumigatus fungus M3

This is a home-collection diagnostic test that measures sensitization to the mold Aspergillus fumigatus by quantifying specific IgE antibodies in a blood sample; samples are processed by a Dubai-certified laboratory to ensure reliable results. Identifying sensitization to Aspergillus fumigatus is clinically important because this fungus can trigger allergic rhinitis, worsen asthma control, and contribute to conditions such as allergic bronchopulmonary aspergillosis (ABPA) or chronic rhinosinusitis.

The test is suited for individuals with persistent or worsening respiratory symptoms, unexplained allergic reactions, recurrent sinus or lower respiratory tract infections, or those with known exposure to damp or moldy environments in the UAE. Results help clinicians decide on targeted management steps—environmental remediation, adjustment of inhaled therapies, consideration of antifungal or biologic treatment, and specialist referral—so you should review findings with your treating physician.

• Aspergillus fumigatus specific IgE (sIgE)
• Sensitization status (Positive / Negative)
• sIgE concentration (kU/L) and semiquantitative class
• Sample type: Serum

• Poorly controlled or deteriorating asthma despite treatment
• Recurrent or chronic sinusitis with suspected fungal involvement
• Clinical suspicion of allergic bronchopulmonary aspergillosis (ABPA)
• Persistent cough or recurrent lower respiratory infections
• Known exposure to indoor mold or damp buildings (home or workplace)

• Convenient home sample collection by trained personnel
• Processed and reported by a Dubai-certified laboratory for accuracy
• Quantitative sIgE values to guide clinical decision-making
• Supports targeted allergy management, environmental remediation and specialist referral
• Helps identify patients at risk for ABPA or mold-driven asthma exacerbations

• At-home venous blood collection by a trained phlebotomist (serum sample)
• No fasting required prior to sample collection
• Inform the collector/lab about recent immunosuppressive therapies, biologics, or allergen immunotherapy
• Provide valid UAE ID and a brief clinical history for accurate interpretation